Novartis India Limited (NOVARTIND.NS) NSE
1,357.90
-107.59998(-7.34%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,357.90
-107.59998(-7.34%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
62
First IPO Date
October 07, 2020
| Name | Title | Pay | Year Born |
| Vasant Narasimhan | Chief Executive Officer of Novartis | 0 | 1976 |
| Falin Ishwarlal Majmudar | WholeTime Director & Head External Supply Operations | 12.21M | 1968 |
| Shilpa Joshi | Chief Financial Officer & Whole-Time Director | 12.53M | 1969 |
| Chandni Maru | Company Secretary & Compliance Officer | 0 | N/A |
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.